Kerala Ayurveda's losses widen even as revenue climbs
Standalone revenue grew 17.6% to ₹85.48 cr, but the net loss deepened to ₹14.74 cr. The auditor flagged unprovided subsidiary receivables.
— 3 earlier stories on Kerala Ayurveda Ltd. →What's new
- Standalone revenue grew 17.6% to ₹85.48 cr but the net loss widened to ₹14.74 cr.
- Consolidated revenue rose 9% to ₹131.15 cr with a consolidated net loss of ₹20.65 cr.
- Audit report contained an emphasis of matter on significant unprovided trade receivables from subsidiaries.
Why this matters
Kerala Ayurveda is adding revenue but losing more money doing it. The standalone loss grew even faster than the topline. The auditor's flag on subsidiary receivables without provision means a portion of the balance sheet may not be collectible, adding an asset-quality question to the operating losses.
What we're watching
- Whether management discloses a plan to collect or write down the flagged subsidiary receivables.
- If the consolidated loss trajectory stabilises as standalone revenue scales.
- Any capital raise to shore up the balance sheet after a loss year.
The full read
Kerala Ayurveda's FY25-26 results show a company adding revenue but deepening losses. Standalone revenue rose 17.6% to ₹85.48 cr, yet the net loss widened to ₹14.74 cr. Costs are growing faster than sales. On a consolidated basis, revenue grew 9% to ₹131.15 cr with a total loss of ₹20.65 cr, meaning subsidiaries are also in the red. The auditor's emphasis on significant, unprovided trade receivables from those subsidiaries is the other problem. A chunk of the company's reported assets may not be collectible. This was a routine annual disclosure, but rising losses paired with an auditor flag on asset quality is the kind of result that demands a clear management answer.
Questions answered
- How did standalone and consolidated results compare?
- Standalone revenue grew 17.6% to ₹85.48 cr with a net loss of ₹14.74 cr. Consolidated revenue, which includes subsidiaries, grew 9% to ₹131.15 cr with a wider net loss of ₹20.65 cr.
- What was the auditor's concern?
- The audit report included an emphasis of matter regarding significant trade receivables owed by subsidiaries for which Kerala Ayurveda has made no provision. If those receivables prove uncollectible, the company's reported assets would be overstated.
- Did the company become more or less profitable on a standalone basis?
- Less profitable. While revenue grew 17.6%, the standalone net loss widened, meaning costs grew faster than sales during the year.
Kerala Ayurveda Ltd.
Latest quarter · Dec 2025
Strength & growth
Story so far
All notes on KERALAYUR →- 25 May 2026 · 8:02 PM IST Kerala Ayurveda's losses widen even as revenue climbs
- 53d ago Kerala Ayurveda targets ₹200 cr revenue by FY27
- 53d ago Kerala Ayurveda's losses widened even as revenue grew
- 53d ago Kerala Ayurveda's losses widen even as top line grows